Evidence map›Paper›PMID 35038939›Full record

ArticleAccountability in research2023

Research integrity during the COVID-19 pandemic: Perspectives of health science researchers at an Academic Health Science Center.

Elise M R Smith, Corisa Rakestraw, Jeffrey S Farroni

Abstract read
In one paragraph

Article in Accountability in research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Revue du rhumatisme (Ed. francaise : 1993) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elise M R SmithDepartment of Preventive Medicine and Population Health, Institute for Translational Sciences, Institute for Bioethics and Health Humanities, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0002-4615-8204
Corisa RakestrawDepartment of Preventive Medicine and Population Health, Institute for the Medical Humanities, University of Texas Medical Branch, Galveston, TX, USA.
Jeffrey S FarroniDepartment of Preventive Medicine and Population Health, Institute for Translational Sciences, Institute for Bioethics and Health Humanities, University of Texas Medical Branch, Galveston, TX, USA.

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
NCATS NIH HHS UL1 TR001439
6 · The paper itself

Abstract

During the coronavirus disease 2019 pandemic, a complex mix of political pressure, social urgency, public panic, and scientific curiosity has significantly impacted the context of research and development. The goal of this study is to understand if and how researchers are shifting their practices and adjusting norms and beliefs regarding research ethics and integrity. We have conducted 31 interviews with Health Science Researchers at the University of Texas Medical Branch which were then analyzed using integrated deductive and inductive coding. We categorized participant views into four main areas: 1) limitations to the research design, 2) publication, 3) duplication of studies, and 4) research pipeline. Although certain researchers were in keeping to the

Indexed as

COVID-19Ethics, ResearchHumansPandemicsResearch PersonnelCOVID-19publicationResearch ethicsresearch integrityscientific system

Identifiers

PMID35038939
PMCPMC9356114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.